Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Solara Active Pharma Q4FY23 results out, revenue grows by 6%
Categories
Health Care
Neuland Laboratories Limited (NEULANDLAB) Q4 FY23 Earnings Concall Transcript
Neuland Laboratories Limited (NSE:NEULANDLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Ravi Udeshi -- Investor Relations Abhijit Majumdar. -- Chief Financial Officer Saharsh
Orchid Pharma Ltd (ORCHPHARMA) Q4 FY23 Earnings Concall Transcript
Orchid Pharma Ltd (NSE:ORCHPHARMA) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Director Analysts: Himanshu Upadhyay -- O3
Sanofi India Ltd (SANOFI) Q4 FY23 Earnings Concall Transcript
Sanofi India Ltd (NSE:SANOFI) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Radhika Kartik Shah -- Company Secretary and Compliance Officer Rodolfo
Medico Remedies Q4FY23 Earnings Story
Medico Remedies is engaged in the business of Manufacture of allopathic pharmaceutical preparations. Financial Results: Medico Remedies Limited reported Total Income for
Neuland Laboratories Q4FY23 Earnings Story
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Orchid Pharma Limited Q4FY23 Earnings Story
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It
Dr. Reddy’s Laboratories Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr. Reddy's Laboratories (DRREDDY) Q4 FY23 Earnings Concall Q&A Highlights: [00:21:55] Mikhaila at Barclays asked more details about the
Lupin Ltd (LUPIN) Q4 FY23 Earnings Concall Transcript
Lupin Ltd (NSE:LUPIN) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director, Global Chief
Aarti Industries Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Aarti Industries Ltd (AARTIIND) Q4 FY23 Earnings Concall Management Update: [00:08:20] AARTIIND said its EBITDA growth guidance for FY24
Novartis India Limited Q4FY23 Earnings Story
The main line of business for Novartis India Ltd. is the wholesale distribution of medicines and medical supplies.It brings different medications into
Procter & Gamble Hygiene & Health Care Q4FY23; 3% Fall in Profits
Procter & Gamble Hygiene & Health Care’s total income in Q4FY23 fell 8% to ₹ 898 crores. Consolidated Profit After Tax came
Lupin Limited Q4FY23 Earnings Story
Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed by Lupin
Sanofi Ltd Q4FY23 results out, revenue soars by 4%
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Company has three brands (Lantus, Allegra, Combiflam) in top
Beta Drugs Limited (BETA) Q4 FY23 Earnings Concall Transcript
Beta Drugs Limited (NSE:BETA) Q4 FY23 Earnings Concall dated May. 09, 2023. Corporate Participants: Rahul Batra -- Chairman and Managing Director Nipun Arora -- Chief Financial
Prevest Denpro Limited (543363) Q4 FY23 Earnings Concall Transcript
Prevest Denpro Limited (BSE:543363) Q4 FY23 Earnings Concall dated May. 09, 2023. Corporate Participants: Atul Modi -- Chairman and Managing Director Namrata Modi -- Executive Director
Poly Medicure Limited Q4FY23 Earnings
A medical equipment producer and exporter with its headquarters in India is called Poly Medicure Limited. The business exports surgical and medical
Windlas Biotech Limited (WINDLAS) Q4 FY23 Earnings Concall Transcript
Windlas Biotech Limited (NSE:WINDLAS) Q4 FY23 Earnings Concall dated May. 08, 2023. Corporate Participants: Hitesh Windlass -- Managing Director Komal Gupta -- Chief Executive Officer &
Alembic Pharmaceuticals Limited (APLLTD) Q4 FY23 Earnings Concall Transcript
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Raj Kumar Baheti -- Director, Finance & Chief Financial Officer
Tatva Chintan Pharma Chem Limited (TATVA) Q4 FY23 Earnings Concall Transcript
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Dinesh Sodani -- GM Finance Chintan Shah -- Managing Director
Ajanta Pharma Limited (AJANTPHARM) Q4 FY23 Earnings Concall Transcript
Ajanta Pharma Limited (NSE:AJANTPHARM) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Yogesh Agrawal -- Managing Director Rajesh Agrawal -- Joint Managing Director Arvind